CD34 and breast cancer: CD34+ similarity, however, separates CP, APcyto, AP and BC cases, indicating increasing similarity of patient gene expression to CD34+ naïve cells with disease progression, and distributes CP patients over more than one order of magnitude, suggesting differences during CP evolution that are not resolved by blast count alone (Fig. 3a).